SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001854270-24-000062
Filing Date
2024-05-17
Accepted
2024-05-17 17:19:13
Documents
4
Period of Report
2024-05-17

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY a20240517pre14adocsentibio.htm PRE 14A 584483
2 image_3.jpg GRAPHIC 19056
3 preliminaryproxycard_p1.jpg GRAPHIC 195035
4 preliminaryproxycard_p2.jpg GRAPHIC 137950
  Complete submission text file 0001854270-24-000062.txt   1070246
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40440 | Film No.: 24961364
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)